Letter to the Editor from Watanabe et al: "Long-term Glycemic Variability and Vascular Complications in Type 2 Diabetes: Post Hoc Analysis of the FIELD Study"

Hirotaka Watanabe; Mitsuyoshi Takahara; Naoto Katakami; Iichiro Shimomura

doi:10.1210/clinem/dgab082

Letter to the Editor from Watanabe et al: "Long-term Glycemic Variability and Vascular Complications in Type 2 Diabetes: Post Hoc Analysis of the FIELD Study"

J Clin Endocrinol Metab. 2021 Apr 23;106(5):e2376-e2377. doi: 10.1210/clinem/dgab082.

Authors

Hirotaka Watanabe¹, Mitsuyoshi Takahara², Naoto Katakami¹, Iichiro Shimomura¹

Affiliations

¹ Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan.
² Department of Diabetes Care Medicine, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan.

PMID: 33564886
DOI: 10.1210/clinem/dgab082

No abstract available

Keywords: dipeptidyl peptidase-4 inhibitors; glucagon-like peptide-1 receptor agonists; long-term glycemic variability; sodiumglucose cotransporter-2 inhibitors; type 2 diabetes.

Publication types

Letter
Comment

MeSH terms

Blood Glucose
Diabetes Mellitus, Type 2* / complications
Dipeptidyl-Peptidase IV Inhibitors*
Humans

Substances

Blood Glucose
Dipeptidyl-Peptidase IV Inhibitors